CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 98 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2018. The put-call ratio across all filers is 0.96 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,000 | -89.5% | 28,540 | -43.4% | 0.00% | – |
| Q3 2018 | $19,000 | -13.6% | 50,415 | 0.0% | 0.00% | – |
| Q2 2018 | $22,000 | -83.7% | 50,415 | -12.3% | 0.00% | -100.0% |
| Q1 2018 | $135,000 | -77.0% | 57,515 | -72.3% | 0.00% | -80.0% |
| Q4 2017 | $588,000 | -10.8% | 207,515 | -10.1% | 0.01% | -16.7% |
| Q3 2017 | $659,000 | +16.0% | 230,715 | -0.0% | 0.01% | +20.0% |
| Q2 2017 | $568,000 | -33.8% | 230,780 | -4.1% | 0.01% | -37.5% |
| Q1 2017 | $858,000 | -1.3% | 240,680 | -2.9% | 0.01% | -11.1% |
| Q4 2016 | $869,000 | -9.4% | 247,870 | +4.1% | 0.01% | -18.2% |
| Q3 2016 | $959,000 | -9.9% | 238,095 | -2.6% | 0.01% | -15.4% |
| Q2 2016 | $1,064,000 | +13.2% | 244,345 | -1.3% | 0.01% | +333.3% |
| Q1 2016 | $940,000 | +33.5% | 247,570 | +456.7% | 0.00% | -62.5% |
| Q4 2015 | $704,000 | +46.7% | 44,470 | -1.8% | 0.01% | +33.3% |
| Q3 2015 | $480,000 | – | 45,274 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |